Published in Am J Trop Med Hyg on February 01, 2005
Severe imported malaria in an intensive care unit: a review of 59 cases. Malar J (2012) 1.32
Morbidity assessment in sand flea disease (tungiasis). Parasitol Res (2006) 0.95
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J (2008) 0.91
Uncommon neurological manifestations of a common tropical vector borne disease. Trop Parasitol (2015) 0.75
Hemoglobin concentration and parasitemia on hospital admission predict risk of multiple organ dysfunction syndrome among adults with malaria. Am J Trop Med Hyg (2014) 0.75
Averting a malaria disaster. Lancet (1999) 9.40
Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis (1989) 8.24
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet (2000) 7.06
Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med (1982) 6.73
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother (2000) 4.77
Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg (2000) 4.63
Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg (1999) 4.60
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health (2004) 4.35
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut (2009) 4.01
Geographical analysis of medical publications in 1990. Lancet (1993) 3.98
Fake artesunate in southeast Asia. Lancet (2001) 3.84
Effects of Plasmodium vivax malaria in pregnancy. Lancet (1999) 3.62
Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother (2000) 3.46
Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans R Soc Trop Med Hyg (2001) 3.32
Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med (1983) 3.07
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg (2001) 3.03
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg (1999) 2.98
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg (2000) 2.76
Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med (1982) 2.71
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chemother (1998) 2.61
Identification of native protein folds amongst a large number of incorrect models. The calculation of low energy conformations from potentials of mean force. J Mol Biol (1990) 2.47
Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med (1996) 2.45
Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet (1998) 2.44
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob Agents Chemother (2001) 2.40
Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in southern Thailand. Trans R Soc Trop Med Hyg (1991) 2.38
The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis (2000) 2.35
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol (2009) 2.31
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther (1999) 2.16
Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase. Br Med J (Clin Res Ed) (1983) 2.15
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet (1992) 2.14
Attenuated corticomedullary contrast: An early cerebral computed tomography sign indicating malignant middle cerebral artery infarction. A case-control study. Stroke (1999) 2.13
Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med (1985) 2.12
Treatment of vivax malaria on the western border of Thailand. Trans R Soc Trop Med Hyg (2000) 2.10
Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J Parasitol (2002) 2.07
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J Trop Med Public Health (1991) 2.06
Parasite multiplication potential and the severity of Falciparum malaria. J Infect Dis (2000) 2.00
Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg (1994) 1.93
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology (2003) 1.90
The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med (1986) 1.90
Prediction of non-survival after trauma: Innsbruck Coma Scale. Lancet (1991) 1.85
Structure-based evaluation of sequence comparison and fold recognition alignment accuracy. J Mol Biol (2000) 1.80
Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Med Hyg (1983) 1.74
Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg (1985) 1.73
Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature. Eur J Neurol (2002) 1.72
Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis (1995) 1.65
Ascaris lumbricoides infection is associated with protection from cerebral malaria. Parasite Immunol (2000) 1.65
Quinidine in falciparum malaria. Lancet (1981) 1.65
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol (2006) 1.64
Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis (1989) 1.64
Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria. Trans R Soc Trop Med Hyg (2005) 1.62
Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis (2001) 1.62
Cerebral vasospasm following temporal lobe epilepsy surgery. Neurology (2012) 1.62
Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet (1985) 1.61
Qualitative and semiquantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure. J Infect Dis (1994) 1.61
The persistent vegetative state after closed head injury: clinical and magnetic resonance imaging findings in 42 patients. J Neurosurg (1998) 1.60
Time course of cerebral blood flow velocity in central nervous system infections. A transcranial Doppler sonography study. Arch Neurol (1993) 1.58
Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol (2006) 1.57
Pharmacokinetics of high-dose oseltamivir in healthy volunteers. Antimicrob Agents Chemother (2008) 1.55
Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human cerebral malaria. Lancet (1988) 1.55
Vitamin D treatment in myelodysplastic syndromes. Br J Haematol (1998) 1.54
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood (2000) 1.54
Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. Am J Trop Med Hyg (2001) 1.54
Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria. Antimicrob Agents Chemother (2000) 1.52
Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option? Eur J Neurol (2004) 1.52
Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival. Stroke (2000) 1.51
Do patients with cerebral malaria have cerebral oedema? A computed tomography study. Lancet (1983) 1.50
A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes. Blood (2001) 1.49
Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol (1983) 1.49
Intrathecal baclofen for intractable spasticity due to severe brain injury. Lancet (1989) 1.48
Differential regulation of IgG subclasses and IgE antimalarial antibody responses in complicated and uncomplicated Plasmodium falciparum malaria. Parasite Immunol (2007) 1.48
Contribution of humoral immunity to the therapeutic response in falciparum malaria. Am J Trop Med Hyg (2001) 1.47
Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1998) 1.47
Efficacy of quinine-tetracycline for acute uncomplicated falciparum malaria in Thailand. Lancet (1992) 1.46
Human cerebral malaria in Thailand: a clinico-pathological correlation. Immunol Lett (1990) 1.44
Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol (1999) 1.44
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg (2000) 1.43
Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am J Trop Med Hyg (1989) 1.43
Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med (1987) 1.40
Images in clinical medicine. Waterhouse-Friderichsen syndrome. N Engl J Med (2001) 1.39
Opisthorchiasis and intestinal fluke infections in northern Thailand. Southeast Asian J Trop Med Public Health (1998) 1.37
Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health (1991) 1.37
Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria. Trans R Soc Trop Med Hyg (1998) 1.36
Quinine and severe falciparum malaria in late pregnancy. Lancet (1985) 1.34
Helminth infections are associated with protection from malaria-related acute renal failure and jaundice in Thailand. Am J Trop Med Hyg (2001) 1.34
Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother (2003) 1.34